Nephrology Pharmaceutical Company - India

Nephrology

SPECIALTY SEGMENT

Nephrology

Nephrology is the branch of medicine that deals with the diagnosis and treatment of kidney diseases. The kidneys are among the most vital organs in the human body — filtering over 150 litres of blood daily, regulating blood pressure, balancing electrolytes and removing waste products.

India is facing a silent epidemic of kidney disease. Chronic Kidney Disease (CKD) affects an estimated 17% of the Indian population — driven primarily by diabetes, hypertension and increasing use of nephrotoxic substances. Yet kidney disease is often detected only at advanced stages, when significant damage has already occurred.

At Quinek Life Sciences, our Nephrology segment provides specialists with a comprehensive range of WHO-GMP certified formulations — from antioxidant renal support and alkalizers to immunosuppressants and dialysis care medicines.

17% of Indians

Affected by Chronic Kidney Disease

2.2 Lakh+

New patients need dialysis every year

13 Products

Across 7 nephrology categories

THE REALITY

Kidney Disease in India — The Numbers

17%

CKD Prevalence

Chronic Kidney Disease affects 1 in 6 Indians — most unaware until late stages

80%

Cases Linked to Diabetes & BP

Diabetic nephropathy and hypertensive kidney disease are the leading causes in India

2.2L+

New Dialysis Patients/Year

India adds over 2.2 lakh new dialysis patients annually — with access still severely limited

90%

Go Undiagnosed Early

CKD has no symptoms in early stages — making regular screening critical for at-risk patients

WHY WE BUILT THIS SEGMENT

CKD Cases in India — A Growing Crisis

The number of CKD patients in India is rising rapidly — driven by the twin epidemics of diabetes and hypertension. Without early intervention and quality medicines, the progression to end-stage renal disease is both predictable and preventable.

Reported CKD Cases (millions) Projected if unaddressed

130M

2019

145M

2020

158M

2021

168M

2022

180M

2023

192M